生命科学资讯

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews

Faster DNA decoding: Illumina’s NovaSeq X gets 40% more data, higher accuracy - Stock Titan

Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - PR Newswire

Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com

San Diego Upstart Drops $100 Genome Bombshell on Illumina - Hoodline

Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina - San Diego Union-Tribune

Illumina earns RS rating upgrade - MSN

Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance

Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com

Illumina To Webcast Upcoming Investor Conference - cnhinews.com

A Look At Illumina (ILMN) Valuation After Profitability Gains And SomaLogic Acquisition Guidance - simplywall.st

Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina

Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma

Illumina: Weak Backlog Support and Rising Competitive Pressures Undermine 2026 Outlook, Justifying Sell Rating - TipRanks

The future of global food security may depend on quality agrigenomics software - Illumina

Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - simplywall.st

Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat

From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina

Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest

Illumina, Inc. $ILMN Stock Holdings Lowered by Rhumbline Advisers - MarketBeat